Kenya

6 Vaccines Approved for Use in Kenya

RNA

Moderna

Spikevax

Approved in 86 countries
63 trials in 22 countries
Approval Source: bloomberg.com
RNA

Pfizer/BioNTech

Comirnaty

Approved in 146 countries
80 trials in 26 countries
Approval Source: health.go.ke
Non Replicating Viral Vector

Gamaleya

Sputnik V

Approved in 74 countries
24 trials in 7 countries
Approval Source: bloomberg.com
Non Replicating Viral Vector

Janssen (Johnson & Johnson)

Ad26.COV2.S

Approved in 111 countries
23 trials in 23 countries
Approval Source: health.go.ke
Non Replicating Viral Vector

Oxford/AstraZeneca

Vaxzevria

Approved in 140 countries
63 trials in 30 countries
Approval Source: gavi.org
Inactivated

Sinopharm (Beijing)

Covilo

Approved in 91 countries
29 trials in 12 countries
Approval Source: bloomberg.com

6 in Clinical Trials in Kenya

Protein Subunit

Novavax

Nuvaxovid

Approved in 37 countries
15 trials in 12 countries
Protein Subunit

Sanofi/GSK

Recombinant Protein

6 trials in 7 countries
Protein Subunit

West China Hospital

Recombinant (Sf9 cell)

7 trials in 4 countries
RNA

Moderna

Spikevax

Approved in 86 countries
63 trials in 22 countries
Non Replicating Viral Vector

Janssen (Johnson & Johnson)

Ad26.COV2.S

Approved in 111 countries
23 trials in 23 countries
Non Replicating Viral Vector

Oxford/AstraZeneca

Vaxzevria

Approved in 140 countries
63 trials in 30 countries